Cargando…
A novel soft-tissue in vitro model for bisphosphonate-associated osteonecrosis
BACKGROUND: Bisphosphonate (BP)-associated osteonecrosis of the jaw (ONJ) has been reported in patients receiving intravenous BP, particularly zoledronic acid (ZA). The purpose of this study was to develop an in vitro model representative of the effects BP has on soft tissue secondary to its release...
Autores principales: | Scheper, MA, Chaisuparat, R, Cullen, KJ, Meiller, TF |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859744/ https://www.ncbi.nlm.nih.gov/pubmed/20359336 http://dx.doi.org/10.1186/1755-1536-3-6 |
Ejemplares similares
-
Bisphosphonate-Associated Osteonecrosis of the Jaw: Are We Dealing with a Localized Non-Traditional Calciphylaxis?
por: Meiller, TF, et al.
Publicado: (2012) -
Impact of Soft Tissue Pathophysiology in the Development and Maintenance of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)
por: Ziebart, Thomas, et al.
Publicado: (2016) -
Osteonecrosis of jaw associated with bisphosphonate use
por: Rastogi, Ashu, et al.
Publicado: (2012) -
Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role
por: Capsoni, Franco, et al.
Publicado: (2006) -
Bisphosphonate-related osteonecrosis of the jaws (Bronj)
por: Beninati, Francesco, et al.
Publicado: (2013)